Assertio Holdings, Inc. (ASRT) Covered Calls

You can sell covered calls on Assertio Holdings, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ASRT (prices last updated Wed 4:16 PM ET):

Assertio Holdings, Inc. (ASRT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.92 +0.04 0.88 0.94 753K - 0.1
Covered Calls For Assertio Holdings, Inc. (ASRT)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 1 0.05 0.89 5.6% 120%
Jun 21 1 0.10 0.84 11.9% 83.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Assertio Holdings, Inc. operates as a specialty pharmaceutical company in the United States. Its specialty pharmaceutical products include CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for treating migraine; Zipsor, an NSAID for relief of mild to moderate acute pain; Gralise, a once-daily formulation of gabapentin for the management of postherpetic neuralgia; NUCYNTA ER, an extended-release version of tapentadol for the management of neuropathic pain associated with diabetic peripheral neuropathy; and NUCYNTA IR, an immediate release version of tapentadol for the management of moderate to severe acute pain. The company has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois.